Sarepta Therapeutics (SRPT) Interest Coverage Ratio (QoQ) (2017 - 2022)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 5.63% |
| Sep 30, 2022 | 28.39% |
| Jun 30, 2022 | -126.32% |
| Mar 31, 2022 | 16.58% |
| Dec 31, 2021 | -295.12% |
| Sep 30, 2021 | 83.88% |
| Jun 30, 2021 | -6.70% |
| Mar 31, 2021 | 38.88% |
| Dec 31, 2020 | -66.02% |
| Sep 30, 2020 | 13.98% |
| Jun 30, 2020 | -28.22% |
| Mar 31, 2020 | 68.41% |
| Dec 31, 2019 | 44.27% |
| Sep 30, 2019 | 84.59% |
| Jun 30, 2019 | 28.07% |
| Mar 31, 2019 | -636.45% |
| Dec 31, 2018 | -499.44% |
| Sep 30, 2018 | 49.25% |
| Jun 30, 2018 | -392.26% |
| Mar 31, 2018 | 22.14% |
| Dec 31, 2017 | 90.97% |
| Sep 30, 2017 | 76.05% |
| Jun 30, 2017 | -56.52% |